WPA
AUPH icon

Wealth Preservation Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History

Wealth Preservation Advisors’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-192
Closed -$2.85K – 155
2026
Q1 		$2.85K Buy
+192
New +$2.81K ﹤0.01% 553

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wealth Preservation Advisors's AUPH Position: Q2 2026 in Review

Wealth Preservation Advisors sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2026, closing a stake of 192 shares — an estimated $2.85K sold.

Wealth Preservation Advisors first reported a position in AUPH in Q1 2026 and held it in 1 quarter. The position peaked at $2.85K in Q1 2026. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Wealth Preservation Advisors reported no remaining Aurinia Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Wealth Preservation Advisors sold 192 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $2.85K.
  • Wealth Preservation Advisors first reported a position in Aurinia Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Wealth Preservation Advisors's Aurinia Pharmaceuticals position peaked at $2.85K in Q1 2026.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Wealth Preservation Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.